Sentences with phrase «radiotherapy patients»

Convergent validity based on a sample of radiotherapy patients found correlations between the subscales and a visual analogue fatigue scale to be 0.77 for general fatigue, 0.70 for physical fatigue, 0.61 for reduced activity, 0.56 for reduced motivation (p < 0.001) to 0.23 for mental fatigue (p < 0.01).38

Almost all prostatectomy patients received robotic surgery, and almost all external beam radiotherapy patients received intensity - modulated radiation, reflecting modern treatment technologies.

Not exact matches

The targeted radiotherapy shrank tumors for 71 % of patients who had already failed standard chemotherapy, but these results came from a small trial that started with 30 patients and then added another 20 after positive data started rolling in.

And we need to ensure that patients have access to the best surgery, radiotherapy and other treatments.

Responding to the announcement from the University of Edinburgh that some older breast cancer patients could safely skip radiotherapy Dr Emma Pennery CBE, Clinical Director at Breast Cancer Care, says:

Breast Cancer Care responds to University of Edinburgh research showing some patients can skip radiotherapy

Speaking on the 31st Convocation lecture of the institution titled» Stepping Out Into The World; Potential Well - Being, Change in Lifestyle And Cancer Education», the don lamented the drain the disease cost on the nation's resources through just about five per cent of the cancer patients (10,000) that had resources to go abroad where they pay between $ 10,000 - $ 15,000 per patient for a three to five weeks course of Radiotherapy.

It is generally agreed that around 50 per cent of cancer patients should receive radiotherapy as part of their treatment.

He continued: «We can conclude from this analysis that the use of G - CSF during thoracic radiotherapy is safe and should support patients to receive the full planned course of concurrent chemo - radiotherapy and achieve the best possible benefit.

This is due to a randomised trial with 215 eligible patients performed between 1989 and 1991, which showed a significant increase in severe thrombocytopenia, severe anemia, pulmonary complications and toxic deaths when granulocyte - macrophage CSFs (GM - CSFs) were used during concurrent chemo - radiotherapy.

Approximately one year after successful treatment with cytotoxic chemotherapy and radiotherapy, patients with advanced Small Cell Lung Cancer (SCLC), which primarily affects heavy smokers, generally relapse with recurrence of tumours that are resistant to further chemotherapy.

Eighty - six patients were identified who received at least two courses of thoracic radiotherapy.

For the analysis presented today, the researchers compared the toxicities and outcomes between patients who received G - CSF during concurrent chemo - radiotherapy and those who did not.

The phase III CONVERT trial enrolled 547 patients with limited - stage SCLC for concurrent chemo - radiotherapy who were randomised to once - daily or twice - daily radiotherapy.

In addition, the Danish Breast Cancer Oncology Group also adopted this partial breast radiotherapy technique for selected patients.

They compared patients» self - reported quality of life related to bowel, urination, and sexual function across four strategies: active surveillance; prostatectomy; external beam radiotherapy; and brachytherapy.

«Now we have evidence to support the use of less, but equally effective, radiotherapy for selected patients.»

Following presentation of the initial results, the UK Royal College of Radiologists 2016 breast radiotherapy consensus stated that partial breast radiotherapy could be considered for selected patients using the IMPORT LOW technique.

Following breast conserving surgery, some patients were treated with whole breast radiotherapy — the clinical standard — while others received partial breast radiotherapy.

Breast cancer patients who have radiotherapy targeted at the original tumour site experience fewer side effects five years after treatment than those who have whole breast radiotherapy, and their cancer is just as unlikely to return, according to trial results published in The Lancet.

But down the hallway in the radiation ward, cancer patients typically get a one - size - fits - all course of radiotherapy, regardless of their genetics or those of their cancer.

«Physicians in regions of high use of radiotherapy may guide patients with DCIS toward mastectomy because many of these patients are ineligible for BCS at the time of a second breast event — having already received radiotherapy — leading to mastectomy being recommended for patients who did not receive radiotherapy and are eligible for BCS.

The study separated patients into clusters based on health service areas (HSAs) and radiotherapy use.

The NIHR - funded researchers, based at The Royal Marsden hospital in London, asked 42 breast cancer patients undergoing radiotherapy to rate how they felt about their body, before the treatment and one month later.

Chemotherapy and radiotherapy alone are relatively unsuccessful in treating the disease, and while surgery to remove the tumour offers the best chance of survival, most patients are diagnosed when the cancer has already spread to other organs.

Invisible tattoos could replace the permanent dark ink tattoos used to ensure that breast cancer patients having radiotherapy are treated in exactly the same spot during each session, according to results from a pilot study to be presented at the National Cancer Research Institute (NCRI) Cancer Conference.

However, in the largest study of its kind so far, scientists from the German Cancer Research Center (DKFZ) in Heidelberg have now shown that the risk of death from heart disease in breast cancer patients following radiotherapy or chemotherapy is no higher than it is among the average population.

As part of the project, announced last week by Kenneth Hagemann, director of the Pentagon's Defense Nuclear Agency, 24 soldiers from Brooks Air Force Base in Texas are taking prescription drugs — ondansetron hydrochloride and granisetron hydrochloride — that are given to cancer patients undergoing radiotherapy or chemotherapy.

«Prostate cancer patients who receive permanent radiotherapy implants twice as likely to be free of cancer after five years.»

Results from a randomised controlled trial to compare the use of permanent radioactive implants (brachytherapy) with dose - escalated external beam radiotherapy in patients with prostate cancer show that the men who received brachytherapy were twice as likely to be cancer - free five years later.

«We have identified a subgroup of older patients at sufficiently low risk of recurrence for whom omission of postoperative radiotherapy after breast - conserving surgery and adjuvant endocrine therapy is a reasonable option.

«Once a patient has had radiotherapy, they are unable to have it again on the same breast.

«Avoiding radiotherapy is an option for some older patients with breast cancer.»

Between 2003 and 2009, 1,326 patients were enrolled in the trial; 658 patients were randomly assigned to receive radiotherapy and 668 did not receive radiotherapy.

Another important aspect of the green - light KTP laser approach, Zeitels adds, is that biopsy and treatment of patients whose cancer involves a single vocal cord usually can be accomplished in the same procedure, whereas radiotherapy requires a prior biopsy to determine the extent and location of the tumor, followed by daily radiation treatments over approximately six weeks.

Rather, cancer patients — whose eggs might be destroyed by chemotherapy or radiotherapy — will benefit the most if this still - experimental procedure becomes practical.

PRIME 2 is an international, phase III, randomized, controlled trial that set out to address the question of whether whole - breast radiotherapy can be omitted in carefully defined groups of older patients receiving appropriate therapy.

«Our results are likely to lead to the consideration of omission of postoperative radiotherapy in patients meeting the eligibility criteria for the trial,» Kunkler said.

The first long - term study of a pioneering endoscopic laser treatment for early vocal - cord cancer, developed at Massachusetts General Hospital (MGH) and previously shown to provide optimal voice outcomes, finds that it is as successful as traditional approaches in curing patients» tumors while avoiding the damage to vocal quality caused by radiotherapy or by conventional laser or cold - instrument surgery.

The investigators found that at five years, 1.3 percent of patients who received radiotherapy had IBTR, and 4.1 percent of patients who did not receive radiotherapy had IBTR.

Chemotherapy or radiotherapy before esophageal surgery did not have any effect on OS or CSS once patients reached the 5 year mark.

In Europe, about 70 % of patients with cervical cancer are cured by either surgery or chemo - radiotherapy.

At Colchester General Hospital, the researchers looked at MR scans taken both before treatment and six weeks after the patients had completed chemotherapy and radiotherapy, and found that the patients whose tumors were less heterogeneous — ie more uniform — in terms of texture parameters six weeks after treatment were more likely to survive longer.

Appearing in Lancet Oncology, long term results of EORTC trial 22921 with 10.4 years median follow - up show that 5 - FU (fluorouracil) based adjuvant chemotherapy after preoperative (chemo)- radiotherapy for patients with cT3 - resectable T4 M0 rectal cancer does not improve survival or disease - free survival.

Whole brain radiotherapy (WBRT) significantly improves tumor control in the brain after SRS, yet because of its association with cognitive decline, its role in the treatment of patients with brain metastases remains controversial.

After the neo-adjuvant chemotherapy, the patients were then given accelerated radiotherapy.

The results will be used to accurately calculate the damage and radiation dose delivered to patients in radiotherapy, when cancer cells are bombarded with ionizing radiation.

Between April 1993 and March 2003, 1011 patients were randomized to four treatment arms, 252 patients received preoperative radiotherapy alone, 253 patients received preoperative radiotherapy — chemotherapy, 253 patients received preoperative radiotherapy followed by adjuvant chemotherapy, and 253 patients received preoperative radiotherapy and chemotherapy followed by adjuvant chemotherapy.

«We had better control over the tumor by giving patients the same overall dose of radiotherapy in fewer sessions and a shorter period of time.

EORTC trial 22921 explored the value of adding chemotherapy to preoperative radiotherapy either concurrently, or as an adjuvant, or both for patients with cT3 - resectable T4 M0 rectal cancer.